Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Arab Emirates

Iraq Violence Threatens Julphar

February 2007 | Company Finance Alert

UAE based drugmaker Gulf Pharmaceutical Industries (Julphar)'s encouraging results in 2006, with sales reaching AED641mn (US$174.5mn), an 18% increase y-o-y, ere achieved despite setbacks in the company's trade with Iraq, caused by the ongoing cycle of bloodshed in the country. Although, demand for Julpar's products remains robust in the war-torn country, the company is finding it increasingly difficult to ship orders.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries